NASDAQ · Financial Statements
Fortress Biotech, Inc. (FBIO) Financial Statements
$1.87
NASDAQ: FBIO
Market Cap $62.37M
Overview Financials Dividend
Fortress Biotech, Inc. most recently reported annual revenue of $63.0M, net profit of $7.0M. Revenue grew at an average annual rate of 6.5% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025
Revenue $69.0M $76.0M $85.0M $58.0M $63.0M Operating Profit $-189.0M $-204.0M $-142.0M $-110.0M $-70.0M Net Profit $-65.0M $-87.0M $-61.0M $-46.0M $7.0M EPS $-11.85 $-14.55 $-8.47 $-2.69 $-0.05 Op Margin -274.1% -268.8% -168.4% -191.4% -111.0%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025
Total Assets $397.0M $294.0M $168.0M $144.0M $186.0M Total Liabilities $171.0M $244.0M $166.0M $146.0M $123.0M Cash $306.0M $178.0M $81.0M $57.0M $79.0M Borrowings $75.0M $127.0M $85.0M $76.0M $74.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $-117.0M $-179.0M $-128.0M $-80.0M $-66.0M Investing Cash Flow $24.0M $-26.0M $-10.0M $-30.0M $10.0M Financing Cash Flow $-5.0M $-8.0M $-1.0M $0 $-1.0M Net Cash Flow $73.0M $-127.0M $-98.0M $-25.0M $22.0M Free Cash Flow $-133.0M $-182.0M $-136.0M $-95.0M $-66.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -0.39 FCF Yield 182.13% Quick Ratio 3.83 Interest Coverage -3.27 Return 1Y 90.31% Return 3Y -52.18% Return 5Y -92.13%
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .